top of page

GPCR News 

Post: Blog2_Post
Writer's pictureGPCR News

Trevena Reports Second Quarter 2022 Results and Provides Business Update

August 2022


"CHESTERBROOK, Pa., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today reported its financial results for the second quarter ended June 30, 2022 and provided an overview of its recent operational highlights." Read more at the source


7 views0 comments

Recent Posts

See All

Commentaires


bottom of page